Literature DB >> 23834922

Cardiopulmonary exercise testing as a diagnostic tool for the detection of left-sided pulmonary hypertension in heart failure.

Marco Guazzi1, Lawrence P Cahalin, Ross Arena.   

Abstract

BACKGROUND: Recently, it has become increasingly recognized that pulmonary hypertension (PH) is a particularly ominous consequence of left-sided heart failure (HF). The primary aim of this investigation was to assess the ability of key cardiopulmonary exercise testing (CPX) variables to detect elevated pulmonary pressures in a HF cohort.
METHODS: This was a retrospective analysis of a prospectively collected database. Two hundred ninety-three subjects with HF (63 ± 10 years old, 79% male) underwent Doppler echocardiography to estimate resting pulmonary artery systolic pressure (PASP). Peak oxygen consumption (VO2), the minute ventilation/carbon dioxide production (VE/VCO2) slope, peak partial pressure of end-tidal CO2 (PETCO2) and exercise oscillatory ventilation (EOV) were determined.
RESULTS: Forty-six percent (n = 134) of the subjects presented with a PASP ≥ 40 mm Hg. A VE/VCO2 slope </≥ 36.0 was the best predictor of a PASP ≥ 40 mm Hg (odds ratio [OR] 12.1, 95% confidence interval [CI] 6.8-21.4; P < .001). Peak PETCO2 ≤ 34 mm Hg (OR 3.8, 95% CI 1.3-11.2; P < .001) and the presence of EOV (OR 3.2, 95% CI 1.8-5.8; P < .001) added significant diagnostic value.
CONCLUSIONS: Although CPX is an established prognostic assessment in the HF population, the results of the present investigation indicate that it may also have important diagnostic utility for PH.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ventilatory efficacy; diagnosis; pulmonary hemodynamics

Mesh:

Year:  2013        PMID: 23834922     DOI: 10.1016/j.cardfail.2013.05.005

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  11 in total

Review 1.  Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 2.  The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot.

Authors:  Frederic Dallaire; Rachel M Wald; Ariane Marelli
Journal:  Pediatr Cardiol       Date:  2017-06-16       Impact factor: 1.655

3.  Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension.

Authors:  Qin-Hua Zhao; Lan Wang; Bigyan Pudasaini; Rong Jiang; Ping Yuan; Su-Gang Gong; Jian Guo; Qiang Xiao; Hui Liu; Cheng Wu; Zhi-Cheng Jing; Jin-Ming Liu
Journal:  Clin Cardiol       Date:  2016-11-02       Impact factor: 2.882

4.  Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia.

Authors:  Tarek Alsaied; Omar Niss; Adam W Powell; Robert J Fleck; James F Cnota; Clifford Chin; Punam Malik; Charles T Quinn; Michael D Taylor
Journal:  Pediatr Blood Cancer       Date:  2018-05-21       Impact factor: 3.167

Review 5.  Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.

Authors:  Yen-Chun Lai; Longfei Wang; Mark T Gladwin
Journal:  J Physiol       Date:  2018-12-30       Impact factor: 5.182

6.  Submaximal Exercise Pulmonary Gas Exchange in Left Heart Disease Patients With Different Forms of Pulmonary Hypertension.

Authors:  Bryan J Taylor; Michael R Smetana; Robert P Frantz; Bruce D Johnson
Journal:  J Card Fail       Date:  2015-04-14       Impact factor: 5.712

Review 7.  Understanding Obesity-Related High Output Heart Failure and Its Implications.

Authors:  Qiuhua Shen; John B Hiebert; Faith K Rahman; Kathryn J Krueger; Bhanu Gupta; Janet D Pierce
Journal:  Int J Heart Fail       Date:  2021-01-13

Review 8.  Cardiopulmonary exercise testing, prehabilitation, and Enhanced Recovery After Surgery (ERAS).

Authors:  Denny Z H Levett; Michael P W Grocott
Journal:  Can J Anaesth       Date:  2015-01-22       Impact factor: 5.063

9.  Cardiopulmonary Exercise Testing as a Tool for Diagnosing Pulmonary Hypertension in Patients with Dilated Cardiomyopathy.

Authors:  Akihiro Hirashiki; Takahisa Kondo; Takahiro Okumura; Yoshihiro Kamimura; Yoshihisa Nakano; Kenji Fukaya; Akinori Sawamura; Ryota Morimoto; Shiro Adachi; Kyosuke Takeshita; Toyoaki Murohara
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-02-01       Impact factor: 1.468

10.  Galectin-3 is related to right ventricular dysfunction in heart failure patients with reduced ejection fraction and may affect exercise capacity.

Authors:  Beata Zaborska; Grażyna Sygitowicz; Krzysztof Smarż; Ewa Pilichowska-Paszkiet; Andrzej Budaj
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.